Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06080503 · ClinicalTrials.gov registry record · NA
Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
A NA study of Laryngeal Carcinoma, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06080503 is a NA study of Laryngeal Carcinoma that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 67 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06080503, a NA study of Laryngeal Carcinoma, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
Conditions Studied
Interventions
- RADIATION LT-SABR
- RADIATION IMRT
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2029-03-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06080503
The ClinicalTrials.gov registry entry for NCT06080503 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Laryngeal Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which LT-SABR is the first listed.
NCT06080503 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06080503 about?
NCT06080503 is a clinical study titled "Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy". To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
What is the current status of trial NCT06080503?
This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-03-14. Estimated completion is 2029-03-14.
What conditions does trial NCT06080503 study?
This clinical trial studies the following conditions: Laryngeal Carcinoma.
What interventions are being tested in trial NCT06080503?
The interventions under investigation include: LT-SABR (RADIATION), IMRT (RADIATION).
Who is sponsoring clinical trial NCT06080503?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06080503 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laryngeal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment
COMPLETED · NA
-
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.